Women who screen for colorectal cancer at 45 reduce risk by 60%

Researchers found a 50 to 60 percent lower risk of colorectal cancer among women who started endoscopy screenings at age 45 compared to those who had not undergone screening at all.

Harvard Gazette • harvard
May 5, 2022 ~4 min

Siren call of daylight saving must be resisted, scientists say

Research, experience point to cancer link and other risks, suggesting standard time would be better year-round choice.

Alvin Powell • harvard
April 5, 2022 ~7 min


Bringing the cancer fight back down to earth

Halving deaths and other Biden goals are in reach, experts say, but let’s forget about "moonshot" and focus on resources and prevention.

Alvin Powell • harvard
March 30, 2022 ~9 min

Closer look at cancer cells’ ability to rewire, thrive, survive

Insights into how cancer cells adapt and rewire their metabolism to achieve growth and survive were accompanied by a call for tools to study this on a nearly single-cell level, according to a new paper in Nature Communications. In the 1920s, Otto Warburg observed that cancer cells metabolically adapt their glucose pathway in unusual ways. […]

Harvard Gazette • harvard
March 24, 2022 ~5 min

Early-stage lung cancer may be detected from a drop of blood

A new study provides proof-of-concept for the ability of a drop of blood to reveal lung cancer in asymptomatic patients.

Anita Slomski • harvard
Dec. 14, 2021 ~5 min

Years after cancer treatment, sleepless nights linger

Researchers found that 51 percent of cancer survivors surveyed experienced sleep disturbances.

Eric Zhou • harvard
Oct. 27, 2021 ~3 min

Experts lower recommended age for colorectal cancer screening

Experts lower the recommended age for colorectal cancer screening.

Harvard Gazette • harvard
May 18, 2021 ~6 min

Researchers reprogram cells to fight brain cancer

Regulatory T cells in the brain can be reprogrammed from guarding glioblastoma tumors to attacking them from within.

Harvard Gazette • harvard
May 13, 2021 ~5 min


New tool developed to study ‘undruggable’ proteins

Researchers at Harvard have designed new, highly selective tools that can add or remove sugars from a protein with no off-target effects, to examine exactly what the sugars are doing and engineer them into new treatments for “undruggable” proteins.

Caitlin McDermott-Murphy • harvard
April 16, 2021 ~7 min

Personalized melanoma vaccines show lasting effects

Researchers at Harvard Medical School and affiliated institutions have shown that a personalized cancer vaccine that is specific to an individual’s tumor has lasting effects, detecting vaccine-related immune system changes years after the vaccine was given.

Alvin Powell • harvard
April 1, 2021 ~12 min

/

5